Curcumin-Based Nanomedicines as Cancer Therapeutics

AvAmirhossein Sahebkar,Prashant Kesharwani

Häftad, Engelska, 2024

1 624 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Curcumin-based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel applications of nanocurcumin in biological milieu as well as helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries.

Nanocurcumin has been widely explored for the treatment of various cancers; however, the scientific literature is inconsistent in style and structure and scattered across many sources. By providing an explicit account on vital aspects on nanocurcumin-based anticancer delivery approaches and discussing the perspectives of the technologies explored so far based upon the findings outlined, the book offers updated and in-depth knowledge on the topic in one single source written by global leading experts.

In addition, the book aims to stimulate the interest of the academic researchers, industrial scientists, businessmen, and young scholars to address key multidisciplinary challenges faced by nanotechnologists to foster the desired collaboration among biologists, chemists, physicists, engineers, and clinicians to find proper and efficient new cancer treatments.

Discusses the complete journey of curcumin delivery from fundamental to most recent anticancer applications using nanotechnology
Provides in-depth knowledge on novel anticancer application of nanocurcumin in biological milieu
Presents reliable and updated information for researchers on nanocurcumin-based anticancer targeted drug delivery

Produktinformation

Utgivningsdatum:2024-02-22
Mått:191 x 235 x 25 mm
Vikt:1 010 g
Format:Häftad
Språk:Engelska
Antal sidor:490
Förlag:Elsevier Science
ISBN:9780443154126

Utforska kategorier

Företagsekonomi inom Ekonomi och Ledarskap
Affärsapplikationer inom Data och IT

Mer om författaren

Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic, experimental, and clinical research on curcuminoids. Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

Innehållsförteckning

Part-A: Curcumin: Introduction, structure, and physicochemical attributes1. Curcumin: historical background, introduction, structure, and physicochemical attributes2. Curcumin as a pharmaceutical leader3. Chemical structure and molecular targets of curcumin for cancer therapy4. Structural features of curcumin and its effects on cancer-related signaling pathways5. An overview of cellular, molecular, and biological aspect(s) of curcumin in cancerPart-B: Smart drug delivery approaches for curcumin delivery in cancer therapy6. Curcumin-drug conjugate-based drug delivery as cancer therapeutics7. Curcumin microcapsule-based drug delivery as cancer therapeuticsPart-C: Recent advances and regulatory aspects of gold nanoparticles8. Nanoemulsion-based curcumin delivery systems as cancer therapeutics9. Micelle-based curcumin delivery systems as cancer therapeutics10. Liposome-based curcumin delivery systems as cancer therapeutics11. Inorganic nanoparticle-based curcumin delivery as cancer therapeutics12. PLGA nanoparticle-based curcumin delivery as cancer therapeutics13. Polymersomes-based curcumin delivery as cancer therapeuticsPart-D: Recent advances in nanocurcumin delivery in cancer therapy14. Biopolymer-based formulations for curcumin delivery toward cancer management15. Nanohybrid drug delivery approach as a novel opportunity for curcumin delivery in cancer16. Codelivery of curcumin and siRNA as anticancer therapeuticsPart-E: Challenges and future perspectives of nano-curcumin drug delivery17. Challenges associated with nanocurcumin anticancer drug delivery systems18. Curcumin-loaded nanoparticles used for in vivo cancer models: an approach about their physicochemical properties and mechanism of action19. Clinical trials, patents, and marketed products of nanocurcumin-based anticancer drug delivery systems